Trial Profile
Reducing Suicidal Ideation Through Insomnia Treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia; Suicidal ideation
- Focus Therapeutic Use
- Acronyms REST-IT
- 20 Sep 2019 Results published in the American Journal of Psychiatry
- 13 Mar 2013 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 25 Sep 2012 New trial record